Source: Procedure Video 2018
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. de Jongh (Enschede, Netherlands), D. Schuermans (Bruxelles, Belgium). Pressurized Metered Dose Inhaler (pMDI) with holding chamber - Correct procedure. Procedure Video 2018

Member's Comments

No comment yet.

Related content which might interest you: Pressurized Metered Dose Inhaler (pMDI) - Correct procedure Source: Procedure Video 2018 Year: 2018 Pressurized Metered Dose Inhaler (pMDI) Delivery to Infants via Valved Holding Chamber (VHC) with Facemask: Not All VHCs Perform the Same Source: International Congress 2017 – Inhalers and their use Year: 2017 Delivery of Respimat Soft Mist inhaler (SMI) from a Valved Holding Chamber (VHC) Source: International Congress 2017 – Inhalers and their use Year: 2017 Assessment of the suitability of filters for use in clinical studies with an HFA fluticasone propionate pressurized metered dose inhaler (pMDI) and a valved holding chamber (VHC) Source: Annual Congress 2011 - Lung function today and tomorrow II Year: 2011 In vitro comparison of aerosol characteristics of HFA albuterol (salbutamol) pressurized metered dose inhaler (pMDI) formulation from three valved holding chambers (VHCs) Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II Year: 2011 Technique: the usual problem of metered dose inhalers Source: Eur Respir J 2002; 20: Suppl. 38, 503s Year: 2002 Valved holding chamber (VHC) angle can affect pressurized netered-dose inhaler (pMDI) medication delivery efficiency Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 Pressurised metered dose inhalers (pMDIs) with integrated flow rate guidance. Source: International Congress 2017 – Pulmonary drug and devices delivery Year: 2017 In vitro evaluation of spacers in comparison with T-adapters in mechanical ventilation with pressurized metered dose inhalers (pMDI) and vibrating mesh nebulizer. Source: International Congress 2019 – COPD and other specific entities in intensive care unit medicine Year: 2019 In vitro comparison of aerosol characteristics of HFA ipratropium bromide pressurized metered dose inhaler (pMDI) formulation from three valved holding chambers (VHCs) Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I Year: 2011 In vitro lung deposition of fluticasone propionate/formoterol (FP/FORM) pressurized metered dose inhaler (pMDI) with different inhalation profiles Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Technique training doesn‘t improve patients ability to use pressurised metered dose inhalers (pMDIs) Source: Annual Congress 2009 - Quality of treatment in primary respiratory care Year: 2009 Device handling study of a novel breath-actuated inhaler Synchrobreathe vs pMDI Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies Year: 2019 Impact of inhalation delay on medication delivery from a salbutamol HFA pressurized metered dose inhaler used with and without a new prototype portable valved holding chamber Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies Year: 2019 Comparison of HFA salmeterol-fluticasone (SFC) combination when given through breath actuated inhaler (BAI) and pressurised meter dose inhaler (pMDI) in patients with moderate-to-severe asthma Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013 Objective measurement of inhalation profiles in patients using metered dose inhalers (MDIs) Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I Year: 2011 The effect of inhalation duration on lung deposition with a pressurized metered-dose inhaler (pMDI) Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Comparison of proficiency of pressurized metered dose inhaler (pMDI) use with asthma control Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 The in vitro fine particle dose with Symbicort Rapihaler pMDI is similar using either NebuChamber or AeroChamber Plus valved holding chamber spacer devices Source: Eur Respir J 2005; 26: Suppl. 49, 504s Year: 2005 Relative pulmonary bioavailability (BA) of fluticasone propionate/formoterol (FP/FORM) via pressurised metered-dose inhaler (pMDI) and a novel breath-triggered inhaler (BTI) Source: International Congress 2017 – Pulmonary drug and devices delivery Year: 2017